Last updated
Planned Medical Treatment Abroad in the EU: S2, Prior Authorisation and Reimbursement Proof
Direct answer
Planned treatment in another EU country is not just a travel question; it is a paperwork and reimbursement route question that needs to be settled before care takes place. This guide explains when readers should be thinking about an S2 form, when another prior authorisation route may matter, and when reimbursement after paying upfront becomes the real issue. It also outlines the evidence file behind those choices, including diagnosis, referral, timing, and treatment-country questions that can decide whether a case moves smoothly or stalls.
Planned-treatment route workflow
The practical question is not only whether treatment abroad is allowed. The user must prove which route applies before travel, who authorises it, and how reimbursement will be calculated.
| Route question | Evidence to gather | Risk if missing |
|---|---|---|
| S2 route | Diagnosis, referral, treatment plan, destination provider, and home institution decision. | The patient travels before the competent institution agrees to planned care abroad. |
| Prior authorisation | National rules, waiting-time evidence, medical necessity, and written approval request. | A reimbursement claim is refused because approval was required first. |
| Direct reimbursement | Invoices, proof of payment, medical records, and comparable domestic tariff evidence. | The user expects full reimbursement when only limited reimbursement is available. |
| Travel timing | Appointment date, approval date, expected stay, and follow-up plan. | The file cannot prove that treatment was planned and authorised in the right order. |
The safest file proves medical need, home coverage, waiting time or access problem, treatment-country provider details, estimated costs and the insurer's written authorisation decision. Do not rely on a clinic's statement that EU rules guarantee payment.
Official sources
- Your Europe: organising planned medical treatment abroad
- Your Europe: planned healthcare expenses and reimbursements
- Your Europe: National Contact Points
- European Commission: social-security coordination rights
decision matrix
| Route | Use when | Key limit |
|---|---|---|
| S2 route | You want direct coverage through public healthcare abroad. | Prior authorisation before travel is needed. |
| Directive reimbursement route | You pay upfront and claim from the home insurer. | Reimbursement is usually capped by home-country rates. |
| No prior check | Only low-risk care clearly not requiring approval. | You carry denial risk if the treatment category was wrong. |
| Urgent or unplanned care | Care becomes necessary during a temporary stay. | Different EHIC or emergency rules may apply. |
Document and evidence checklist
- Diagnosis, referral and specialist opinion explaining why treatment is needed.
- Evidence the treatment is covered by your home public health system.
- Waiting-time evidence or access problem at home, if relevant to authorisation.
- Prior authorisation application, S2 request and insurer decision.
- Treatment-country provider name, address, public or private status and estimate.
- Travel dates, planned treatment dates and follow-up plan.
- Invoices, receipts, discharge summary and reimbursement claim documents after treatment.
When S2 is the better question
Your Europe explains that the S2 option involves prior authorisation and generally direct coverage between institutions for public healthcare abroad. It is particularly relevant where the treatment is included in your coverage but cannot be provided at home within a medically justifiable time. If granted, the treatment-country rules and rates matter.
Ask whether the provider abroad is public or accepted under the S2 route. A private clinic may still treat you, but that does not mean S2 direct coverage applies.
Decision questions before applying
Before applying for S2 or prior authorisation, decide which route you are asking for and why. If you want direct coverage, the S2 route and public provider status are central. If you are prepared to pay upfront, the reimbursement route may be different. Mixing both routes in one unclear request can produce a refusal that is hard to appeal.
Ask your doctor to separate medical need from travel preference. The institution needs to know whether the treatment is covered, clinically justified and unavailable at home within an acceptable time, not simply that the foreign provider is preferred. A focused application gives the insurer a concrete decision to make.
Common evidence gaps
S2 and prior-authorisation files often fail because the medical need is documented but the administrative route is not. Attach the treatment plan, but also attach the proof that the treatment is covered at home, the reason it cannot be provided at home within a medically justifiable time where relevant, and the identity of the public provider abroad. If the treatment date changes, keep the updated appointment proof.
Do not leave the insurer to infer urgency. Ask the treating doctor to state the clinical reason for treatment, the consequences of delay and the relevant timeframe. If the insurer proposes domestic treatment instead, ask for the provider, date and clinical suitability. A strong file compares real options, not abstract statements that care is unavailable or better abroad.
If travel, accommodation or companion costs are material, ask separately whether any of them are covered. Treatment authorisation does not automatically mean every related cost is reimbursed. Keep these costs out of the core medical claim unless the insurer's rule specifically allows them.
Timing and deadlines
Apply for prior authorisation before booking non-refundable travel or paying deposits. Give the insurer enough time to assess medical need and coverage. If treatment is time-sensitive, ask your doctor to state the clinical urgency and the latest medically justifiable treatment date.
After treatment, submit reimbursement documents quickly if any payment remains your responsibility. Keep the S2, invoices and discharge documents together, because institutions may request proof months later.
Risks
The main risks are travelling before authorisation, assuming private care is covered, misunderstanding tariff differences, failing to prove the treatment is covered at home, and ignoring follow-up care. You may also face language and medical-record transfer problems if the provider abroad does not give documents in a usable format.
Do not treat S2 as a general travel insurance document. It is linked to specific planned treatment and authorisation conditions.
Fallback and appeal
If S2 or prior authorisation is refused, ask for written reasons and the appeal deadline. The insurer may say the treatment is not covered, can be provided at home in time, lacks medical justification, or is outside the requested route. Your appeal should address that reason with medical and administrative evidence.
If you already had treatment without authorisation, ask whether reimbursement after self-payment is still possible under national rules. Do not assume denial of S2 ends every possible claim, but do not assume another route will cover the full bill.
Bottom line
Planned treatment abroad is a pre-travel decision, not a post-travel paperwork exercise. Get the route, provider status, authorisation and reimbursement basis in writing before costs are incurred.